{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20250421",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "81990",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761390Orig1s001ltr.pdf",
              "date": "20250425",
              "type": "Letter"
            },
            {
              "id": "81999",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761390s001lbl.pdf",
              "date": "20250425",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20240812",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "79382",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761390s000lbl.pdf",
              "date": "20240813",
              "type": "Label"
            },
            {
              "id": "79386",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761390Orig1s000ltr.pdf",
              "date": "20240813",
              "type": "Letter"
            },
            {
              "id": "79570",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2024/761390Orig1s000TOC.html",
              "date": "20240910",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20250626",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "82679",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761391Orig1s001,761390Orig1s002ltr.pdf",
              "date": "20250627",
              "type": "Letter"
            },
            {
              "id": "82762",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761390s002,761391s001lbl.pdf",
              "date": "20250710",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "BLA761390",
      "sponsor_name": "GALDERMA LABS LP",
      "openfda": {
        "application_number": [
          "BLA761390"
        ],
        "brand_name": [
          "NEMLUVIO"
        ],
        "generic_name": [
          "NEMOLIZUMAB-ILTO"
        ],
        "manufacturer_name": [
          "Galderma Laboratories, L.P."
        ],
        "product_ndc": [
          "0299-6220"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "NEMOLIZUMAB"
        ],
        "rxcui": [
          "2691325",
          "2691328"
        ],
        "spl_id": [
          "df0e2be2-b6bd-40e5-9175-0c8e893433ea"
        ],
        "spl_set_id": [
          "e9229ef1-ac60-4c24-afb6-009d3c781687"
        ],
        "package_ndc": [
          "0299-6220-15",
          "0299-6220-10"
        ],
        "nui": [
          "N0000194121",
          "N0000194122"
        ],
        "pharm_class_epc": [
          "Interleukin-31 Receptor alpha Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Interleukin-31 Receptor alpha Antagonists [MoA]"
        ],
        "unii": [
          "GN465U8B72"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "NEMLUVIO",
          "active_ingredients": [
            {
              "name": "NEMOLIZUMAB-ILTO",
              "strength": "30MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}